Heranba Industries Ltd
Heranba Industries Ltd Q3 FY24 Results & Presentation Highlights: Revenue ₹301.70 Cr, PAT ₹19.22 Cr
Q3 FY24 investor presentation: what the company reported on revenue, margins and projects.
Based on Heranba Industries Ltd's Q3 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q3FY24 Standalone Revenue from Operations: ₹301.70 crore; up from ₹280.20 crore in Q3FY23, a ~7.7% YoY increase (Page 17). - Q3FY24 Consolidated Revenue from Operations: ₹299.66 crore; down from ₹276.00 crore in Q3FY23, a ~8.5% YoY increase (Page 18). - Q3FY24 Standalone EBITDA Margin: 11.58%, compared to 9.41% in Q3FY23 (Page 17). - Q3FY24 Standalone PAT: ₹19.22 crore, compared to ₹14.40 crore in Q3FY23 (Page 17). - Q3FY24 Management Commentary outlook: The company expects to accelerate revenue growth, enhance productivity, expand product registrations and grow its customer base. Q3FY24 Standalone EBITDA (incl.
From Heranba Industries Ltd's Q3 FY24 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q3FY24 Standalone Revenue from Operations: ₹301.70 crore; up from ₹280.20 crore in Q3FY23, a ~7.7% YoY increase (Page 17).
- Q3FY24 Consolidated Revenue from Operations: ₹299.66 crore; down from ₹276.00 crore in Q3FY23, a ~8.5% YoY increase (Page 18).
- Q3FY24 Standalone EBITDA Margin: 11.58%, compared to 9.41% in Q3FY23 (Page 17).
- Q3FY24 Standalone PAT: ₹19.22 crore, compared to ₹14.40 crore in Q3FY23 (Page 17).
- Q3FY24 Management Commentary outlook: The company expects to accelerate revenue growth, enhance productivity, expand product registrations and grow its customer base. FY24 is seen as a crucial acceleration point in Heranba’s growth trajectory (Page 15).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Heranba Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Ongoing capex at Sarigam and Saykha facilities is progressing well (Page 15).
- Capital Work-in-Progress increased from ₹37.77 crore in FY20 to ₹54.99 crore in H1FY24, indicating ongoing investments (Page 23).
- Enhancing Production Capabilities is part of business strategy to exploit agrochemical market growth (Page 28).
- No specific amounts or detailed timelines for capex or new plants/projects are explicitly stated in the presentation.
2 more points management made on capital expenditure plans
Top-ranked in Fertilizers & Agrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Heranba Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Heranba Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹319 Cr, net loss ₹58 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Heranba Inds's management said in earlier quarters
- Q4 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q4 FY23 earnings call analysis →
- Q1 FY24 earnings call analysis →
- Q2 FY25 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q1 FY23 earnings call →
- Q4 FY22 earnings call →
- Q2 FY22 earnings call →
- Q2 FY22 earnings call →
- Q1 FY22 earnings call →
Others in Fertilizers & Agrochemicals this season
- Sumitomo Chemical India Ltd (Q3 FY24)
542.0 Cr, down 28% YoY from Rs. Key investor presentation takeaways from Sumitomo Chemical India Ltd's Q3 FY24 investor presentation — and how it ranks against
- Dharmaj Crop (Q3 FY24)
Q3FY24 Revenue from Operations: ₹123.4 crore, a 22% YoY increase from ₹101.1 crore in Q3FY23 (Page 6). Key investor presentation takeaways from Dharmaj Crop Gua
Frequently Asked Questions
What were Heranba Industries Ltd Q3 FY24 results?
Q3FY24 Standalone Revenue from Operations: ₹301.70 crore; up from ₹280.20 crore in Q3FY23, a ~7.7% YoY increase (Page 17). - Q3FY24 Consolidated Revenue from Operations: ₹299.66 crore; down from ₹276.00 crore in Q3FY23, a ~8.5% YoY increase (Page 18). - Q3FY24 Standalone EBITDA Margin: 11.58%, compared to 9.41% in Q3FY23 (Page 17). - Q3FY24 Standalone PAT: ₹19.22 crore, compared to ₹14.40 crore in Q3FY23 (Page 17). - Q3FY24 Management Commentary outlook: The company expects to accelerate revenue growth, enhance productivity, expand product registrations and grow its customer base. Q3FY24 Standalone EBITDA (incl.
What is Heranba Industries Ltd share price analysis?
Heranba Industries Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹668 Cr. Investors should review the full earnings analysis for detailed insights.
Is Heranba Industries Ltd planning capital expenditure?
Ongoing capex at Sarigam and Saykha facilities is progressing well (Page 15). - Capital Work-in-Progress increased from ₹37.77 crore in FY20 to ₹54.99 crore in H1FY24, indicating ongoing investments (Page 23). - Enhancing Production Capabilities is part of business strategy to exploit agrochemical market growth (Page 28). - No specific amounts or detailed timelines for capex or new plants/projects are explicitly stated in the presentation. - The company focuses on strengthening R&D, enhancing formulation & technicals, and entering regulated markets as strategic growth levers, implying supporting investments (Page 28). - No explicit completion dates or detailed schedules provided. Summary: The presentation references ongoing capex at Sarigam and Saykha facilities with good progress but does not specify exact amounts or timelines.
Keep Heranba Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.